Skip to main content
3342 Results
 
msf-placeholder
HIV/AIDS

Not owning a watch does not prevent effective AIDS treatment

Fred Minandi, a farmer, is one of the patients in Malawi taking ARV treatment for AIDS through an MSF project. Speaking at the AIDS Conference, he challenged one of the key myths of providing proper treatment to people in Africa - that Africans cannot tell the time. Project Update - 11 Jul 2002
 
msf-placeholder
HIV/AIDS

AIDS and promises - an alphabet soup of good intentions

G8, EU, OAU, UNGASS and the WTO have all made elaborate promises for the Global Fund. But the reality is, of the $2.08 billion that has been pledged, only $700-800 million will be available for disbursal in 2002. This figure is less than a tenth of what is estimated to be required each year to tackle AIDS alone Project Update - 9 Jul 2002
 
msf-placeholder
HIV/AIDS

Why is the West ignoring AIDS?

As Africa-style Aids epidemics are set to spread to Eastern Europe and India, the richer nations are only giving a fraction of what's needed. Magin McKenna reports on a battle to save the world. Project Update - 7 Jul 2002
 
msf-placeholder
HIV/AIDS

MSF at the XIV International AIDS Conference

MSF is attending the XIV International AIDS Conference from July 8-12 in Barcelona, Spain. On July 7, MSF is presenting a half-day satellite meeting along with Health GAP (Global Access Project) on the theme of transforming AIDS treatment from right to reality. Project Update - 7 Jul 2002
 
msf-placeholder
HIV/AIDS

Costing AIDS by prevention alone is simplistic

AIDS destroys adults as workers, parents, and care givers in the prime of their lives. Treatment saves children from orphanhood; keeps households, social cohesion, and businesses intact; improves returns on social investments, such as education and
development; increases growth and security; and keeps to a minimum exacerbation of poverty.
Project Update - 6 Jul 2002
 
msf-placeholder
Thailand

Advances in Thailand often due to AIDS activism

A debate confined to issues of cost-effectiveness is too narrow, and polarisation of the debate into a prevention versus HAART argument will not help either cause. Project Update - 6 Jul 2002
 
msf-placeholder
HIV/AIDS

Cost-effectiveness is no measure for medical treatment

Rather than accepting the price of drugs as immutable, WHO should be putting more energy into working with UNAIDS to bring the price of antiretrovirals within
reach, calling for more funding and contesting those worldwide forces that keep billions of people in perpetual poverty.
Project Update - 6 Jul 2002
 
msf-placeholder
World AIDS Day

World AIDS experts debate

With the world finally coughing up a bit of cash to address the global AIDS pandemic, an agonizing debate is resurfacing: How much should be spent to treat those already infected and how much should be spent on preventing others from getting infected? Project Update - 3 Jul 2002
 
msf-placeholder
Angola

Over 280 tonnes of food shipped to Angola to maintain MSF feeding centres

With 44 feeding centres, MSF is caring for over 14,000 people. The new supplies ensure operations for the next three months - but the emergency shall remain for up to a year. Project Update - 1 Jul 2002
 
msf-placeholder
Neglected diseases

The Lancet: Drugs for neglected diseases

Lack of scientific knowledge is not the major barrier to drug development. Selection is based on potential profits, not global public health concerns. This system obviously fails the needs of poor countries. Project Update - 1 Jul 2002
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more